COLCHICINE RESISTANCE FAMILIAL MEDITERRANEAN FEVER (CRFMF)

Clinical trials for COLCHICINE RESISTANCE FAMILIAL MEDITERRANEAN FEVER (CRFMF) explained in plain language.

Never miss a new study

Get alerted when new COLCHICINE RESISTANCE FAMILIAL MEDITERRANEAN FEVER (CRFMF) trials appear

Sign up with your email to follow new studies for COLCHICINE RESISTANCE FAMILIAL MEDITERRANEAN FEVER (CRFMF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Real-World watch: tracking a drug for rare, debilitating fevers

Disease control Recruiting now

This study aims to monitor the safety and effectiveness of the drug Ilaris (canakinumab) in real-world clinical settings. It will include children and adults with rare hereditary fever syndromes or a form of juvenile arthritis who are already receiving the drug as part of their s…

Matched conditions: COLCHICINE RESISTANCE FAMILIAL MEDITERRANEAN FEVER (CRFMF)

Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 13, 2026 15:06 UTC

COLCHICINE RESISTANCE FAMILIAL MEDITERRANEAN FEVER (CRFMF)

Get alerted when new COLCHICINE RESISTANCE FAMILIAL MEDITERRANEAN FEVER (CRFMF) trials appear

Real-World watch: tracking a drug for rare, debilitating fevers